CHRONIC HEMODYNAMIC-EFFECTS OF CARVEDILOL IN ESSENTIAL-HYPERTENSION AT REST AND DURING EXERCISE

被引:11
|
作者
LUNDJOHANSEN, P
OMVIK, P
机构
[1] Section of Cardiology, Medical Department, University of Bergen, School of Medicine, Haukeland Hospital
关键词
HYPERTENSION; HEMODYNAMICS; CARDIAC OUTPUT; EXERCISE; BETA-BLOCKERS; CARVEDILOL;
D O I
10.1093/oxfordjournals.eurheartj.a060160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nineteen men (mean age 44 years) with essential hypertension, WHO stage I, were studied invasively at rest and during exercise. Blood pressure was recorded in intra-arterially (brachial artery), cardiac output by dye dilution method and heart rate by electrocardiography. After initial pre-drug recordings, the patients received 25 mg carvedilol orally and central haemodynamics at rest and during exercise were recorded 1 and 2 h after tablet in take to evaluate the immediate effects of curvedilol. The results indicated a combined β-blocking and vasodilating effect. After 6-9 months of treatment, supine haemodynamics were recorded 12-24 h after the last dose and then 1 and 2 h after an additional 25 mg dose. During chronic treatment (2 h after last dose at rest supine) mean arterial pressure was reduced by 17% (P <0.001) and total peripheral resistance index by 6% (NS) while heart rate and cardiac index were reduced by 12%. Exercise haemodynamics demonstratedafall in bloodpressure of 17% (P <0.001). Exercise stroke index increased by 5% (NS), partly compensatingfor the reduction in heart rate of 17%. Total peripheral resistance index was reduced by 5% (NS). It is concluded that carvedilol is an effective anti-hypertensive agent in a large proportion of patients with essential hypertension. The haemodynamic mode of action reflects an a1-blocking activity, particularly in situations with low sympathetic tone. During exercise the β1-blocking activity (demonstrated by the reduction in heart rate) is more prominent. © 1992 The European Society of Cardiology.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [41] In-vivo intracellular pH at rest and during exercise in patients with essential hypertension
    Khong, TK
    McIntyre, DJO
    Sagnella, GA
    Markandu, ND
    Miller, MA
    Baker, EH
    Griffiths, JR
    MacGregor, GA
    JOURNAL OF HYPERTENSION, 2001, 19 (09) : 1595 - 1600
  • [42] HUMORAL EFFECTS OF PERINDOPRIL IN ESSENTIAL-HYPERTENSION
    SAGNELLA, GA
    MARKANDU, ND
    SINGER, DRJ
    BUCKLEY, MG
    MILLER, MA
    MACGREGOR, GA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (06) : 625 - 626
  • [43] RENAL EFFECTS OF IMMERSION IN ESSENTIAL-HYPERTENSION
    LAROCHELLE, P
    CUSSON, JR
    DUSOUICH, P
    HAMET, P
    SCHIFFRIN, EL
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (02) : 120 - 128
  • [44] SYMPATHONEURAL AND HEMODYNAMIC CHARACTERISTICS OF YOUNG SUBJECTS WITH MILD ESSENTIAL-HYPERTENSION
    FLORAS, JS
    HARA, K
    JOURNAL OF HYPERTENSION, 1993, 11 (06) : 647 - 655
  • [45] SAFETY OF THE COADMINISTRATION OF CARVEDILOL AND NIFEDIPINE SUSTAINED-RELEASE IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
    JUTTMANN, JR
    ROBLES, PD
    VENUTI, RP
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S134 - S137
  • [46] A MULTICENTER COMPARISON OF CARVEDILOL WITH HYDROCHLOROTHIAZIDE IN THE TREATMENT OF MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
    LANGDON, CG
    BAXTER, GA
    YOUNG, PH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S51 - S56
  • [47] COMPARISON OF THE EFFECTS OF CARVEDILOL AND NIFEDIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    ALBERGATI, F
    PATERNO, E
    VENUTI, RP
    BOERI, D
    LOMBARDO, I
    SEMINO, S
    VIVIANI, GL
    ADEZATI, L
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S86 - S89
  • [48] Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation
    Lundgren, Jakob
    Radegran, Goran
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (07):
  • [49] COMBINED TERAZOSIN AND VERAPAMIL THERAPY IN ESSENTIAL-HYPERTENSION - HEMODYNAMIC AND PHARMACOKINETIC INTERACTIONS
    LENZ, ML
    POOL, JL
    LADDU, AR
    VARGHESE, A
    JOHNSTON, W
    TAYLOR, AA
    AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (02) : 133 - 145
  • [50] HEMODYNAMIC AND ENDOCRINE CHANGES ASSOCIATED WITH HYPOTENSIVE ACTION OF AMOSULALOL IN ESSENTIAL-HYPERTENSION
    ANDO, K
    NODA, H
    OGATA, E
    FUJITA, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (01) : 7 - 10